Ikarian Capital, LLC 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:34 pm Sale | 2021-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | Ikarian Capital, LLC | 28 1.000% | -83 (-74.77%) | Filing |